Randomized Controlled Trial of Clozapine and CBT for First-Episode Psychosis with Enduring Positive Symptoms: A Pilot Study
- PMID: 22937265
- PMCID: PMC3420683
- DOI: 10.1155/2011/394896
Randomized Controlled Trial of Clozapine and CBT for First-Episode Psychosis with Enduring Positive Symptoms: A Pilot Study
Abstract
Here we report the results of a pilot study investigating the relative and combined effects of a 12 week course of clozapine and CBT in first-episode psychosis patients with prominent ongoing positive symptoms following their initial treatment. Patients from our early psychosis service who met the inclusion criteria (n = 48) were randomized to one of four treatment groups: clozapine, clozapine plus CBT, thioridazine, or thioridazine plus CBT. The degree of psychopathology and functionality of all participants was measured at baseline then again at 6, 12 and 24 weeks, and the treatment outcomes for each group determined by statistical analysis. A substantial proportion (52%) of those treated with clozapine achieved symptomatic remission, as compared to 35% of those who were treated with thioridazine. Overall, those who received clozapine responded more rapidly to treatment than those receiving the alternative treatments. Interestingly, during the early treatment phase CBT appeared to reduce the intensity of both positive and negative symptoms and thus the time taken to respond to treatment, as well having as a stabilizing effect over time.
Figures
References
-
- Craig T, Fennig S, Tanenberg-Karant M, Bromet EJ. Six-month clinical status as a predictor of 24-month clinical outcome in first-admission patients with schizophrenia. Annals of Clinical Psychiatry. 1999;11(4):197–203. - PubMed
-
- Edwards J, Maude D, McGorry PD, Harrigan SM, Cocks JT. Prolonged recovery in first-episode psychosis. British Journal of Psychiatry. 1998;172(33):107–116. - PubMed
-
- Wahlbeck K, Cheine M, Essali A, Adams C. Evidence of clozapine’s effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. American Journal of Psychiatry. 1999;156(7):990–999. - PubMed
-
- American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. The American Journal of Psychiatry. 1997;154(4, supplement):1–63. - PubMed
-
- McGorry P. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Australian and New Zealand Journal of Psychiatry. 2005;39(1-2):1–30. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous